Overview
POM market data
Price History
POM price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$13.53 Diluted earnings per share over the trailing twelve months.
- Beta
- 2.20 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -26.3% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.50 – $115.74 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $6.4M · P/S 0.08.
Company News
POMDOCTOR Regains Nasdaq ComplianceBenzinga · Jul 13, 2026, 12:07 PM
POMDOCTOR Announces Strategic Upgrade, Positioning As Infrastructure Provider For Predictive Healthcare Data And ServicesBenzinga · Jul 2, 2026, 12:10 PM
Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News PendingBenzinga · Jun 18, 2026, 11:55 PM
POMDOCTOR Plans To Change Ratio Of Adss To Class A Ordinary Shares From Current Ratio Of One ADS Representing One-Sixth Class A Ordinary Share To New Ratio Of One ADS Representing Three Class A Ordinary SharesBenzinga · May 28, 2026, 12:25 PM
Pomdoctor FY EPS $(3.14), Sales $57.187MBenzinga · May 14, 2026, 8:53 PM
Small Chinese Firms Withdraw Wall Street IPO ApplicationsBenzinga · May 14, 2026, 4:15 PM